SCHEMBL20736593

SCHEMBL20736593

c1ccc2c(c1)-c1ccccc1C21c2cc(-c3ccc(-c4cn5ccccc5n4)cc3)c3ccccc3c2-c2ccc3ccccc3c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 13/20 0.43
▸ KDM4E B2RXH2 12/20 0.43
▸ NPC1 O15118 11/20 0.43
▸ POLB P06746 3/20 0.43
▸ GFER P55789 3/20 0.42
▸ PKM P14618 5/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MIF P14174 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.39
▸ ALDH1A1 P00352 8/20 0.39
▸ SMN1; SMN2 Q16637 7/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ HPGD P15428 4/20 0.38
▸ MAPT P10636 4/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27250494 0.88 RAB9A (0.44) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20736385 0.88 RAB9A (0.41) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20736216 0.87 RAB9A (0.45) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20737199 0.86 RAB9A (0.45) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20736589 0.86 ALDH1A1 (0.46) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20735974 0.84 RAB9A (0.44) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20735968 0.83 RAB9A (0.45) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20737262 0.83 RAB9A (0.42) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20737167 0.83 RAB9A (0.41) RAB9AKDM4ENPC1POLBGFER
SCHEMBL20737227 0.80 KDM4E (0.34) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 RAB9A 1517/4885KDM4E 2169/4885NPC1 1857/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 RAB9A 1517/4885KDM4E 2169/4885NPC1 1857/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 RAB9A 1517/4885KDM4E 2169/4885NPC1 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback